KI to formulate 10 year commercialisation plan

The Karolinska Institute in Stockholm is working on a long-term strategy for commercialising its research after raising €63 million on the Swedish Stock Exchange, reports Science Business.

The plan is due to be ready early next year. “Innovation will be at the core of Karolinska,” Bo-Ragnar Tolf, the recently appointed head of the institute’s innovation office told the publication.